FOXP3 and gastric cancer: (92) established an IS based on the densities of CD3+, CD8+, and Foxp3+ T-lymphocytes in CT and IM regions of 389 patients who underwent surgical resection for stage II/III GC and received adjuvant chemotherapy with 5-FU.